Free Trial

Leerink Partnrs Forecasts Weaker Earnings for agilon health

agilon health logo with Medical background

agilon health, inc. (NYSE:AGL - Free Report) - Equities researchers at Leerink Partnrs reduced their Q2 2025 earnings per share estimates for shares of agilon health in a note issued to investors on Wednesday, May 7th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of ($0.13) for the quarter, down from their previous forecast of ($0.09). The consensus estimate for agilon health's current full-year earnings is ($0.59) per share. Leerink Partnrs also issued estimates for agilon health's Q3 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.11) EPS, FY2025 earnings at ($0.35) EPS, Q2 2026 earnings at ($0.06) EPS, Q3 2026 earnings at ($0.07) EPS, Q4 2026 earnings at ($0.08) EPS, FY2026 earnings at ($0.20) EPS and FY2027 earnings at ($0.14) EPS.

A number of other research firms have also weighed in on AGL. Sanford C. Bernstein raised agilon health from a "market perform" rating to an "outperform" rating and raised their price objective for the company from $3.30 to $8.50 in a research report on Tuesday, April 8th. Wells Fargo & Company reduced their price objective on agilon health from $6.00 to $5.00 and set an "overweight" rating for the company in a research report on Tuesday. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Citigroup raised agilon health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $3.25 to $5.00 in a research report on Friday, April 25th. Finally, JMP Securities reaffirmed a "market perform" rating on shares of agilon health in a research report on Monday, April 28th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $4.90.

View Our Latest Analysis on agilon health

agilon health Stock Down 1.8%

Shares of NYSE:AGL traded down $0.05 during trading on Monday, hitting $2.51. The stock had a trading volume of 488,911 shares, compared to its average volume of 4,885,731. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $1.04 billion, a PE ratio of -2.66 and a beta of 0.38. The firm's fifty day moving average is $4.21 and its 200 day moving average is $3.19.

agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period last year, the company earned ($0.02) EPS. agilon health's revenue for the quarter was down 4.5% compared to the same quarter last year.

Institutional Investors Weigh In On agilon health

Several large investors have recently added to or reduced their stakes in the stock. Barclays PLC boosted its position in shares of agilon health by 21.2% during the third quarter. Barclays PLC now owns 1,228,952 shares of the company's stock valued at $4,830,000 after buying an additional 214,830 shares during the period. JPMorgan Chase & Co. increased its position in agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after buying an additional 1,083,492 shares in the last quarter. Pines Wealth Management LLC purchased a new position in agilon health in the 4th quarter worth $51,000. Oak Thistle LLC purchased a new position in agilon health in the 4th quarter worth $25,000. Finally, Inspire Investing LLC raised its stake in agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock worth $413,000 after acquiring an additional 112,241 shares during the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Earnings History and Estimates for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines